Education
About Us
Working with TipRanks
Follow Us
BINV - ETF AI Analysis
Top Page
Brandes International ETF (BINV)
Rating:58Neutral
Price Target:―
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries, including the U.S., Europe, and Asia, which helps reduce the impact of problems in any single market.
Balanced Sector Mix
Holdings are spread across health care, consumer, industrial, technology, financial, and other sectors, helping avoid heavy dependence on just one industry.
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year to date, suggesting its strategy has been working well recently.
Negative Factors
Relatively High Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns are used to cover fees instead of going to investors.
Mixed Results Among Top Holdings
While several top positions have performed strongly, at least one major holding has been weak this year, which can drag on overall returns.
Significant U.S. Weight in an International Fund
Despite being an international ETF, a large share of assets is invested in U.S. companies, which may reduce the pure overseas diversification some investors are seeking.
BINV vs. SPDR S&P 500 ETF (SPY)
AUM468.41M
RegionGlobal
Expense Ratio0.70%
Beta0.58
IssuerBrandes
Inception DateOct 03, 2023
Dividend Yield2.13%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume62,840
30 Day Avg. Volume58,540
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
49.69Price Target Upside― Downside
Rating ConsensusHold
Number of Analyst Covering64
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BINV Summary
Brandes International ETF (BINV) is an actively managed fund that looks for undervalued stocks in markets outside the U.S., rather than tracking a set index. It invests across many countries and sectors, with a focus on finding companies that may be priced lower than what they’re really worth. Well-known holdings include Alibaba and Sanofi. Someone might invest in BINV to diversify beyond the U.S. and seek long-term growth from international value stocks. A key risk is that international stock prices can be volatile and may rise or fall sharply with global market conditions.
How much will it cost me?The Brandes International ETF (BINV) has an expense ratio of 0.7%, which means you’ll pay $7 per year for every $1,000 invested. This is higher than average because it is actively managed, meaning experts are selecting stocks rather than following a passive index.
What would affect this ETF?The Brandes International ETF (BINV) could benefit from global economic recovery and increased consumer spending, particularly in sectors like Consumer Defensive and Health Care, which are heavily weighted in its portfolio. However, it may face challenges from rising interest rates or geopolitical tensions that could impact international markets and the performance of its top holdings, such as Sanofi and Alibaba. Additionally, regulatory changes in emerging markets could pose risks to some of its investments.
BINV Top 10 Holdings
BINV is leaning heavily on international health care and consumer names, with GSK, Astellas, and Takeda setting the tone. GSK and Astellas have been rising and look like key engines for the fund, while Takeda is more mixed, occasionally losing steam despite a decent longer-term trend. On the consumer side, Wilmar, Heineken, and Henkel are quietly steady to rising, giving the portfolio a defensive backbone. Alibaba and BNP Paribas add a more cyclical, recovery flavor, helping performance lately and underscoring the fund’s global, value-tilted reach beyond the U.S.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Takeda Pharmaceutical Co | 2.77% | $12.85M | ¥8.85T | 43.90% | 66 Neutral | |
| GlaxoSmithKline | 2.66% | $12.35M | $118.11B | 61.71% | 77 Outperform | |
| STMicroelectronics NV | 2.55% | $11.80M | €25.77B | 26.02% | 71 Outperform | |
| Sanofi | 2.47% | $11.46M | €100.00B | -12.00% | 75 Outperform | |
| Astellas Pharma | 2.44% | $11.30M | $29.74B | 68.54% | ― | |
| Heineken Holding NV | 2.21% | $10.24M | €19.80B | 0.82% | 76 Outperform | |
| Henkel AG & Co. KGaA | 2.11% | $9.80M | €32.73B | 1.16% | 73 Outperform | |
| Wilmar International | 2.08% | $9.65M | S$21.85B | 24.88% | 69 Neutral | |
| Carrefour | 2.07% | $9.61M | €11.11B | 10.25% | 66 Neutral | |
| ― | 2.03% | $9.42M | ― | ― | ― |
BINV Technical Analysis
Negative
―
Price Trends
42.29
Negative
40.60
Positive
38.42
Positive
Market Momentum
0.16
Positive
37.26
Neutral
21.96
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BINV, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 43.87, equal to the 50-day MA of 42.29, and equal to the 200-day MA of 38.42, indicating a neutral trend. The MACD of 0.16 indicates Positive momentum. The RSI at 37.26 is Neutral, neither overbought nor oversold. The STOCH value of 21.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for BINV.
BINV Peer Comparison
Comparison Results
Performance Comparison
BINV
Brandes International ETF
42.03
8.32
24.68%
BKDV
BNY Mellon Dynamic Value ETF
―
―
―
GMOI
GMO International Value ETF
―
―
―
FPAG
FPA Global Equity ETF
―
―
―
COPY
Tweedy Browne Insider + Value ETF Trust Units
―
―
―
MFSV
MFS Active Value ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents